Discover how Pikamoon revolutionizes Play-to-Earn gaming with a fun-first, free-to-play model and sustainable $PIKA tokenomics. Join the PikaRoyale battle now.
Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback